title: Meningococcemia in vaccinated patient under treatment with eculizumab.
authors.affiliation: Sección de Microbiología, Hospital General de Segovia, Segovia, España. Electronic address: shernando@saludcastillayleon.es.
authors.forename: Susana
authors.initials: S
authors.lastname: Hernando Real
authors.affiliation: Sección de Microbiología, Hospital General de Segovia, Segovia, España.
authors.forename: Silvia
authors.initials: S
authors.lastname: Vega Castaño
authors.affiliation: Servicio de Medicina Intensiva, Hospital General de Segovia, Segovia, España.
authors.forename: Rafael
authors.initials: R
authors.lastname: Pajares García
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000276:immunology; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D015373:Bacterial Typing Techniques; D002439:Cefotaxime / Q000627:therapeutic use; D004630:Emergencies; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D000071497:Immunogenicity, Vaccine; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D022401:Meningococcal Vaccines / Q000276:immunology; D009345:Neisseria meningitidis / Q000145:classification / Q000302:isolation & purification*; D014611:Vaccination; D055815:Young Adult
chemical_list: C570015:4CMenB vaccine; D000900:Anti-Bacterial Agents; D061067:Antibodies, Monoclonal, Humanized; D000942:Antigens, Bacterial; D007166:Immunosuppressive Agents; D022401:Meningococcal Vaccines; C481642:eculizumab; D002439:Cefotaxime